NCT01083160 - Clinical Outcomes, Compliance and Effectiveness of Switching From Infliximab or Etanercept to Adalimumab in Patients With Active Rheumatoid Arthritis (RA). A Multicenter Post-Marketing Observational Study in Routine Clinical Use | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions

Rheumatoid Arthritis

Trial Locations (12)

Site Reference ID/Investigator# 28057, Tuxtla Gutiérrez

Site Reference ID/Investigator# 27882, Chihuahua City

Site Reference ID/Investigator# 27883, Chihuahua City

Site Reference ID/Investigator# 25943, Leon, Gto.

Site Reference ID/Investigator# 27888, Guadalajara, Jal.

Site Reference ID/Investigator# 27886, Guadalajara, Jal.

Site Reference ID/Investigator# 27887, Guadalajara, Jal.

Site Reference ID/Investigator# 27890, Puebla, Pue.

Site Reference ID/Investigator# 27889, Puebla, Pue.

Site Reference ID/Investigator# 27884, Culiacán Sin.

Site Reference ID/Investigator# 28059, Mexico City

Site Reference ID/Investigator# 27885, Mexico City